Ethyl Silicate 40

We are Ethyl Silicate 40 CAS:11099-06-2 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:Ethyl Silicate 40
CAS.NO:11099-06-2 or 68412-37-3
Synonyms:Ethyl Polysilicate 40
Molecular Formula:C24H60016Si5
Molecular Weight:750
 
Physical and Chemical Properties:
Density:1.05-1.07;
Melting point:oC;
Boiling point:160oC;
Flash point:62oC;
Index of Refraction:1.397;
 
Specification:
Appearance:Colorless transparent liquid
Active Content:≥99.0%
 
Packing:200 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:It is used to deposit silicic acid formed as a result of complete hydrolysis. The resulting silicic acid bonds well to many inorganic substrates, such as ceramic, fillers, glass, metal, pigments and synthetic fibers. The deposition of a thin SiO2 layer improves the chemical and the thermal stability and mechanical properties.
It may be used as a binder in zinc-rich(corrosion resistant) coating.
It may be used as a starting material for sol-gel process.
It may be used as a crosslinker component in cold curing silicone rubber systems.
It may be used as a hardening component in dentistry for impression materials and as binder for embedding material.
It may be used as a binder in precision foundry indust

Ethyl Silicate 40


Related News: This is of vital important and underlies one of the most solid principles and regulations of modern pharmacy.3-cloro-1,2-benzotiazol 1,1-dióxido CAS:567-19-1 This is of vital important and underlies one of the most solid principles and regulations of modern pharmacy.bisphenol AF CAS:1478-61-1 Patents covering oral and injectable rigosertib have been issued in the US and are expected to provide coverage until at least 2037.1- (2-yodoetil) -4-octilbenceno CAS:162358-07-8 The drug review center will establish a registration platform and database for APIs, pharmaceutical excipients and pharmaceutical packaging materials, which means that the domestic drug substance DMF system is expected to be gradually implemented.The drug review center will establish a registration platform and database for APIs, pharmaceutical excipients and pharmaceutical packaging materials, which means that the domestic drug substance DMF system is expected to be gradually implemented.

Related Products
Product Name
3-Bromo-4-fluorobenzoic Acid View Details
Aminosalicylate Sodium View Details
2-(4-bromophenyl)-4-phenylquinazoline View Details
2-[[(2S)-4-methyl-2-[(2-methylpropan-2-yl)oxycarbonylamino]pentanoyl]amino]acetic acid manufacturer o-Acetoacetaniside manufacturer (1R,2S)-2-(phenylmethoxymethyl)cyclopent-3-en-1-ol manufacturer 1-(4-Bromophenyl)naphthalene manufacturer 3-Methyl-1,5-pentanediol manufacturer